The mitochondrial respiratory chain is a major source of reactive oxygen species (ROS) under pathological conditions including myocardial ischemia and reperfusion. Limitation of electron transport by the inhibitor rotenone immediately before ischemia decreases the production of ROS in cardiac myocytes and reduces damage to mitochondria. We asked if ROS generation by intact mitochondria during the oxidation of complex I substrates (glutamate, pyruvate/malate) occurred from complex I or III. ROS production by mitochondria of Sprague-Dawley rat hearts and corresponding submitochondrial particles was studied. ROS were measured as H 2 O 2 using the amplex red assay. In mitochondria oxidizing complex I substrates, rotenone inhibition did not increase H 2 O 2 . Oxidation of complex I or II substrates in the presence of antimycin A markedly increased H 2 O 2 . Rotenone prevented antimycin A-induced H 2 O 2 production in mitochondria with complex I substrates but not with complex II substrates. Catalase scavenged H 2 O 2 . In contrast to intact mitochondria, blockade of complex I with rotenone markedly increased H 2 O 2 production from submitochondrial particles oxidizing the complex I substrate NADH. ROS are produced from complex I by the NADH dehydrogenase located in the matrix side of the inner membrane and are dissipated in mitochondria by matrix antioxidant defense. However, in submitochondrial particles devoid of antioxidant defense ROS from complex I are available for detection. In mitochondria, complex III is the principal site for ROS generation during the oxidation of complex I substrates, and rotenone protects by limiting electron flow into complex III.
Reactive oxygen species (ROS) 1 contribute to a number of pathological processes including aging (1-3), apoptosis (4) , and cellular injury during ischemia and reperfusion (5, 6) . The mitochondrial electron-transport chain is the main source of ROS during normal metabolism (6, 7) . The rate of ROS production from mitochondria is increased in a variety of pathologic conditions including hypoxia (8) , ischemia (9) , reperfusion (5, 10) , aging (1, 2) , and chemical inhibition of mitochondrial respiration (11, 12) .
Complex I and complex III of the electron-transport chain are the major sites for ROS production (11, 12) . Complex I inhibition by rotenone can increase ROS generation in submitochondrial particles (12, 13) . The oxidation of either complex I or complex II substrates in the presence of complex III inhibition with antimycin A increases ROS (1, 13, 14) . However, the major site of production of reactive oxygen species in mitochondria oxidizing complex I substrates remains unclear. In the pathologic condition of myocardial ischemia, administration of rotenone decreases the production of ROS (8) and ameliorates damage to mitochondria during ischemia in the isolated rat heart (15) . These data suggest that rotenone inhibition of complex I decreases rather than increases ROS production by mitochondria during ischemia.
Myocardial ischemia results in a decrease in oxidation through cytochrome oxidase in intact mitochondria (6, 16 -18) . Although cytochrome oxidase is not a source of ROS (19 -21) , inhibition of cytochrome oxidase may facilitate ROS production from complexes I or III (22) . Cytochrome oxidase inhibition by KCN enhanced myocardial damage during reperfusion (5), suggesting that blockade of electron flow at cytochrome oxidase increased both ROS generation and oxidative damage during reperfusion.
Mitochondria and submitochondrial particles commonly are used to study ROS generation. Compared with mitochondria, submitochondrial particles lack matrix antioxidant enzymes (23) and have a mixed orientation of the inner mitochondrial membrane (24) . These features may result in different findings when the production of ROS is compared between mitochondria and submitochondrial particles. In the present study, we used mitochondria and corresponding submitochondrial particles prepared from Sprague-Dawley rat heart to test the following: 1) if blockade of proximal electron flow decreases ROS generation from complex III in mitochondria and submitochondrial particles, 2) if complex IV inhibition enhances ROS generation during the oxidation of complex I or complex II substrates, 3) if matrix antioxidant defense dissipates ROS production from either complex I or complex III.
EXPERIMENTAL PROCEDURES
Materials-All chemicals were reagent grade and purchased from Sigma. Supplies for the amplex red assay were obtained from Molecular Probes (Eugene, OR).
Mitochondria Isolation-The Animal Care and Use Committee for the Louis Stokes Veterans Affairs Medical Center approved the protocol. Male Sprague-Dawley rats (400 -500 g) were euthanized, and the hearts from those rats were isolated and put into buffer A (containing (in mM) 100 KCl, 50 MOPS, 1 EGTA, 5 MgSO 4 ⅐7H 2 O, and 1 ATP, pH 7.4) at 4°C. Cardiac subsarcolemmal mitochondria were isolated using the procedure of Palmer et al. (25) . Cardiac tissue was finely minced, placed in buffer A containing 0.2% bovine serum albumin, and homogenized with a Polytron tissue processor (Brinkmann Instruments) for 2.5 s at a rheostat setting of 6.0. The Polytron homogenate was centrifuged at 500 ϫ g, the supernatant was saved for isolation of subsarcolemmal mitochondria, and the pellet was washed. The combined supernatants were centrifuged at 3000 ϫ g to sediment subsarcolemmal mitochondria, which were washed twice and then suspended in KME (100 mM KCl, 50 mM MOPS, and 0.5 mM EGTA). Some of the mitochondria were used for studies of mitochondrial oxidation and H 2 O 2 production, and the remainder was frozen at Ϫ70°C for the preparation of submitochondrial particles. Mitochondrial protein concentration was determined by the Lowry method, using bovine serum albumin as a standard.
Preparation of Submitochondrial Particles-Subsarcolemmal mitochondria from 2 to 3 rats were pooled together for the preparation of submitochondrial particles. Frozen mitochondria were thawed and diluted with 10 mM MOPS to a concentration of ϳ10 -20 mg of protein/ml. The mitochondria were sonicated for 20 s in a salt-ice-water bath (Ϫ4°C) at 60% of maximal output in a Branson sonifier, followed by a 2-min interval. After 9 cycles, the suspension was centrifuged at 16,000 ϫ g for 10 min. The supernatant was decanted and centrifuged at 150,000 ϫ g for 45 min (24, 26) . The pellet was resuspended in 10 mM MOPS, and the protein concentration was determined.
Mitochondrial Oxidative Phosphorylation-Oxygen consumption in mitochondria was measured using a Clark-type oxygen electrode at 30°C (16) . Mitochondria were incubated in solution including 80 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM KH 2 PO 4 , and 1 mg/ml bovine serum albumin at pH 7.4. Glutamate was used as substrate, and state 3 (ADP-stimulated), state 4 (ADP-limited) respiration, respiratory control ratios, and the ADP/O ratio were determined (16) .
Detection of H 2 O 2 Production-The rate of H 2 O 2 production in mitochondria and submitochondrial particles was determined using the oxidation of the fluorogenic indicator amplex red in the presence of horseradish peroxidase (2) . The concentrations of horseradish peroxidase and amplex red in the incubation were 0.1 unit/ml and 50 M, respectively. Fluorescence was recorded in a microplate reader (1420 Victor2, PerkinElmer Life Sciences) with 530 nm excitation and 590 nm emission wavelengths. Standard curves obtained by adding known amounts of H 2 O 2 to assay medium in the presence of the reactants (amplex red and horseradish peroxidase) were linear up to 2 M. Background fluorescence was measured in the absence of submitochondrial particles or mitochondria and presented as fluorescence minus background (pmol/mg of protein/30 min). The addition of superoxide dismutase did not increase the rate of production of H 2 O 2 indicating that under assay conditions, the non-enzymatic dismutation of superoxide to H 2 O 2 was sufficiently rapid and complete. In a typical experiment, mitochondria or submitochondrial particles were incubated at 0.1 mg of protein/ml at 30°C. H 2 O 2 production was initiated in mitochondria using glutamate (10 mM), pyruvate (2.5 mM)/malate (2.5 mM), or succinate (5 mM) as substrates. Substrates used with submitochondrial particles were NADH (80 M) or succinate (5 mM). Rotenone (2.4 M), antimycin A (10 M), and azide (10 mM) were added into incubation medium to inhibit the activities of complex I, complex III, and complex IV, respectively. Because thenoyltrifluoroacetone caused a high background fluorescence, malonate (2.5 mM), a succinate dehydrogenase inhibitor, was used to block complex II (27) . Stigmatellin (6.6 M) was used to test whether blockade of complex III at the Q o site, limiting electron flow into complex III, reduced H 2 O 2 generation. The addition of catalase (643 units/ml) decreased fluorescence by 85-90% as expected and was used to dissipate H 2 O 2 in the incubation system. The rate of H 2 O 2 production was linear with respect to mg of mitochondrial protein.
Statistical Analyses-Data are expressed as means Ϯ S.E. of the mean. One-way analysis of variance with repeated measurements was used to assess the difference between different inhibitors in mitochondria. A difference of p Ͻ 0.05 was considered to be significant.
RESULTS
Oxidative Phosphorylation-Oxidative phosphorylation was studied in mitochondria with glutamate as the substrate. The state 3 (0.2 mM ADP-stimulated), state 4, and maximal ADP (2 mM)-stimulated respiratory rates (n ϭ 5) were 230 Ϯ 4, 35 Ϯ 3, and 260 Ϯ 6 nAO min Ϫ1 mg protein Ϫ1 , respectively, consistent with previous results (25, 26) . Respiratory control ratio and ADP/O ratio were 7.1 Ϯ 0.8 and 2.78 Ϯ 0.12. These results indicated that mitochondrial respiration was tightly coupled.
H 2 O 2 Production in Mitochondria-Oxidizing glutamate, mitochondria generated minimal H 2 O 2 in the absence of inhibitors (Fig. 1A) . Surprisingly, the complex I inhibitor rotenone did not lead to an additional increase in H 2 O 2 production. Complex III inhibition by antimycin A markedly increased H 2 O 2 production, as expected (11) . Rotenone inhibition prevented antimycin A-induced H 2 O 2 production in the mitochondria oxidizing glutamate (Fig. 1A) . Stigmatellin attenuated the antimycin A-induced H 2 O 2 production in mitochondria oxidizing glutamate (Table I) . Azide inhibition did not increase H 2 O 2 by mitochondria in the presence of glutamate (Table II) . Catalase dissipated most of the ROS production by antimycin A indicating that the increase in fluorescence measured was because of H 2 O 2 (Fig. 1A) .
Because rotenone did not increase H 2 O 2 production in mitochondria oxidizing glutamate, pyruvate/malate was used as a second complex I substrate to confirm the results with glutamate. In agreement with the glutamate results, mitochondria oxidizing pyruvate/malate generated minimal H 2 O 2 (Fig. 1B) . Inhibition of complex I with rotenone did not increase H 2 O 2 production in mitochondria oxidizing pyruvate/malate compared with the absence of inhibitors (Fig. 1B) . Rotenone prevented antimycin A-mediated H 2 O 2 generation in mitochondria oxidizing pyruvate/malate (Fig. 1B) , as did stigmatellin (Table  I ). Azide did not increase H 2 O 2 generation in mitochondria oxidizing pyruvate/malate (Table II) .
With succinate as substrate, mitochondria produced minimal H 2 O 2 in the presence of rotenone (Fig. 1C) . Antimycin A markedly increased H 2 O 2 production in mitochondria oxidizing succinate in the presence of rotenone (Fig. 1C) . Malonate, a complex II inhibitor, significantly decreased antimycin A-induced H 2 O 2 generation in mitochondria oxidizing succinate (Fig. 1C) . Stigmatellin attenuated antimycin A-induced H 2 O 2 production in mitochondria oxidizing succinate (Table I ). Azide did not increase H 2 O 2 generation in mitochondria in the presence of succinate (Table II) .
H 2 O 2 Production in Submitochondrial Particles-Because submitochondrial particles are unable to oxidize glutamate or pyruvate/malate (24), NADH was used as the complex I substrate. In contrast to the situation in mitochondria, rotenone inhibition markedly increased H 2 O 2 production in submitochondrial particles oxidizing NADH (Fig. 2A) . Similar to findings in mitochondria, antimycin A markedly increased H 2 O 2 production in submitochondrial particles oxidizing NADH. In submitochondrial particles oxidizing NADH, rotenone/antimycin A produced the same amount of H 2 O 2 as did rotenone alone. Interestingly, stigmatellin only partially blocked antimycin Ainduced H 2 O 2 generation in submitochondrial particles oxidizing NADH (Fig. 2A) . In contrast to results obtained with mitochondria, azide markedly increased H 2 O 2 production from submitochondrial particles oxidizing NADH (Table II) . Antimycin A increased H 2 O 2 production in submitochondrial particles oxidizing succinate, whereas stigmatellin attenuated antimycin A-induced H 2 O 2 production (Fig. 2B) . Complex IV inhibition with azide did not significantly increase H 2 O 2 generation in submitochondrial particles oxidizing succinate in the presence of rotenone (Table II) . DISCUSSION In the present study, we found that the production of reactive oxygen species measured as H 2 O 2 differed substantially in mitochondria and corresponding submitochondrial particles. In intact mitochondria, rotenone inhibition of complex I did not increase ROS production with complex I substrates. In contrast, rotenone markedly increased ROS production in submitochondrial particles oxidizing NADH. Inhibition of complex III with antimycin A increased the production of ROS during the oxidation of complex I substrates in both mitochondria and submitochondrial particles. Rotenone inhibition prevented antimycin A-induced ROS generation in mitochondria oxidizing complex I substrates. However, ROS production during NADH oxidation in the presence of rotenone and antimycin A remained increased in submitochondrial particles.
Rotenone blocks complex I near the binding site for ubiquinol, the electron acceptor for complex I (28). Blockade of complex I at this distal site in the complex increases the reduction of the NADH dehydrogenase site of complex I, increasing electron leak to ROS (12) . Thus, rotenone blockade should enhance, not decrease, oxyradical production by complex I. The observation of rotenone-enhanced production of H 2 O 2 in submitochondrial particles oxidizing NADH is consistent with this mechanism and with previous observations (12, 29) . The NADH dehydrogenase site of electron leak from complex I is located in the matrix side of the inner mitochondrial membrane (30) . Thus, oxidant production from complex I is directed into the mitochondrial matrix and would either result in mitochondrial damage or be inactivated by matrix-antioxidant enzyme systems (23, 31) . Thus, in mitochondria, ROS production from complex I is likely to be directed into the matrix and detoxified by matrix antioxidant defense systems (Fig. 3) . MnSOD will form H 2 O 2 from superoxide (23), with H 2 O 2 in turn inactivated by glutathione catalyzed by glutathione peroxidase (31, 32) or catalase (33) . Compared with mitochondria, submitochondrial particles are largely devoid of matrix antioxidant enzymes and have an inverted membrane orientation (23, 24) . Thus, the NADH dehydrogenase can release superoxide into the bulk solution in the absence of antioxidant defense. The observation that rotenone inhibition significantly increased H 2 O 2 production in submitochondrial particles oxidizing NADH supports the finding that complex I is capable of robust H 2 O 2 production. The finding that rotenone inhibition led to only a minimal increase in H 2 O 2 production in mitochondria suggests that complex I is not the major site of net ROS generation in mitochondria that are oxidizing complex I substrates.
Complex III is a key site for ROS generation (11, 14, 34, 35) . Complex III has two centers: the Q o center, oriented toward the intermembrane space; and the Q i center, located in the inner membrane and facing the mitochondrial matrix. Superoxide produced at the Q o center is released into the intermembrane space (14, 36, 37) (Fig. 3) , whereas superoxide generated at the Q i center is likely to enter the matrix. Antimycin A inhibits complex III at the Q i center and increases superoxide generation from the Q o center, directing oxidants away from matrix antioxidant defense (35) (36) (37) (38) . In the present study, antimycin A markedly increased H 2 O 2 generation in both mitochondria and submitochondrial particles oxidizing complex I substrates, supporting the idea that the ROS from the complex III Q o center is basically unaffected by antioxidant defense. In the present study, rotenone inhibition prevented antimycin A-induced H 2 O 2 production in mitochondria oxidizing complex I substrates. Complex II inhibition with malonate attenuated antimycin A-induced ROS generation in mitochondria oxidizing succinate. Stigmatellin blocks electron transport into complex III at the Q o center (34) leading to a similar attenuation of ROS produced from the complex in the presence of antimycin A. These results suggest that complex III is the main site for net ROS generation in mitochondria, and blockade of electron flow upstream of complex III minimizes ROS production in mitochondria that are oxidizing complex I substrates. This observation suggests a likely mechanism for the observations that administration of rotenone (15) or a succinate-dehydrogenase inhibitor (39) before myocardial ischemia occurs decreases damage to the myocardium.
Myocardial ischemia decreases cytochrome oxidase activity (16 -18) . Cytochrome oxidase inhibition augments myocardial oxidative damage (5) . Cytochrome oxidase inhibition does not increase ROS production from complex IV (19 -21) but leads to increased reduction of redox centers in complex I or complex III, enhancing electron leak and ROS generation from these complexes (22) . In the current study, azide did not increase H 2 O 2 production in mitochondria oxidizing either complex I or complex II substrates. This observation makes complex IVdriven H 2 O 2 generation from the Q o center of complex III less likely. However, azide increased H 2 O 2 generation in submitochondrial particles oxidizing complex I substrates, yet H 2 O 2 production from submitochondrial particles oxidizing succinate was not increased. This observation suggests that azide probably enhances ROS generation from complex I. Because ROS generated at complex I are released into the matrix as discussed above, azide inhibition of complex IV did not enhance ROS generation in mitochondria. In contrast, inhibition of cytochrome oxidase enhanced ROS generation in submitochondrial particles oxidizing NADH, but not succinate, reinforcing the notion of complex I as the major site of ROS production when the electron-transport chain is inhibited at cytochrome oxidase.
By introducing a relative block at the Q o site of complex III, inhibition of cytochrome oxidase may augment the production of ROS from complex I but not from complex III. When cytochrome oxidase is inhibited, cytochrome c is reduced (40) , leading to an increased relative reduction of cytochrome c 1 in complex III (34, 41) . According to the structure-function model of electron flow through complex III (41, 42) , when cytochrome c 1 is reduced the iron-sulfur protein cannot dock with cytochrome c 1 , leading to disruption of oxidation of ubiquinol at the Q o site, effectively blocking electron entry into complex III (34, 41 block at the Q o site could attenuate oxyradical production from complex III but increase the relative reduction of complex I, leading, in turn, to leak from the NADH dehydrogenase portion of the complex. This proposed mechanism is consistent with the data in the present study that inhibition of cytochrome oxidase enhances ROS production in submitochondrial particles but not in intact mitochondria with complex I substrates.
During myocardial ischemia, complex III enhances the production of reactive oxygen species in myocytes (8) and the intact heart (9). Complex III, probably via oxidative mechanisms, mediates damage to the electron-transport chain in hearts (15) . The results of oxidant production following inhibition of cytochrome oxidase obtained in the present study in non-ischemic cardiac mitochondria, as discussed above, strongly suggest that inhibition of complex IV during ischemia cannot be the sole mechanism of enhanced mitochondrial-mediated production of oxidants during ischemia. Thus, ROS production from complex III during ischemia appears to require an additional defect that increases oxidant production from the Q o site. During ischemia, complex III sustains damage to the iron-sulfur peptide with loss of the electron paramagnetic resonance signal in this key component of ubiquinol oxidation at the Q o site (26) . Functional alterations of the Q o site can disrupt electron flux in this portion of complex III leading to "bypass reactions" of the Q o site that enhance ROS production (43) . Thus, ischemic damage may enhance oxidant production from the Q o site of complex III that is blunted by intervention with rotenone (8, 15) , which limits flow into complex III. Our findings suggest that when complex III is modified to increase oxidant production from the Q o site either by the chemical inhibitor antimycin A (11), or perhaps by ischemic damage (26) , that inhibition of electron flow upstream of complex III will decrease ROS generation.
Interestingly, stigmatellin did not totally block antimycin A-induced ROS generation in submitochondrial particles oxidizing NADH. This suggests that stigmatellin alone causes ROS generation (23) . Stigmatellin blocks electron flow at the Q o site of complex III (34) and will lead to the accumulation of electrons at complex I, enhancing ROS production from this upstream complex in a similar manner to rotenone.
In conclusion, complex III is the primary site for net ROS generation in mitochondria and limiting electron flow into complex III prevents ROS production in these organelles. Complex III is the dominant site because ROS products are directed away from the antioxidant defenses of the matrix. In contrast, complex I releases oxidants in the proximity of defense enzyme systems. Inhibition of cytochrome oxidase enhances the production of ROS from certain upstream sites in the electrontransport chain, surprisingly mostly from complex I.
